Hotline:
+ 49 (0) 2204 2918806

Market studies for category Oncology/Hematology

Items 1 to 10 of 2139 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 214
  1. Net price*
    Year
  2. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Herpes Labialis (Oral Herpes) – Pipeline Review, H2 2012

    Global Markets Direct
    43 pages
    Introduction Global Markets Direct’s, 'Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Herpes Labialis (Oral Herpes), complete with latest updates, and special features on late-stage and discont
    Englisch | Report | SKU: 317925
  3. $2,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018

    Global Markets Direct
    155 pages
    Introduction Global Markets Direct’s new report, ”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment
    Englisch | Report | SKU: 318565
  4. $3,495.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Novoseven RT (Hemophilia A and B) - Forecast and Market Analysis to 2022

    GlobalData
    42 pages
    The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. Howe
    Englisch | Zukunftsanalyse | SKU: 387161
  5. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Hypopharyngeal Cancer – Pipeline Review, H2 2012

    Global Markets Direct
    50 pages
    Introduction Global Markets Direct’s, 'Hypopharyngeal Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypopharyngeal Cancer, complete with latest updates, and special features on late-stage and discontinued projects.
    Englisch | Pipeline Review | SKU: 317637
  6. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Plague – Pipeline Review, H2 2012

    Global Markets Direct
    59 pages
    Introduction Global Markets Direct’s, 'Plague - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Plague, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players in
    Englisch | Report | SKU: 318277
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Other Dermatological Disorders – Pipeline Review, H1 2013

    Global Markets Direct
    41 pages
    Introduction Global Markets Direct’s, 'Other Dermatological Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Other Dermatological Disorders, complete with latest updates, and special features on late-stage and disco
    Englisch | Report | SKU: 324423
  8. $2,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Blepharitis – Pipeline Review, H2 2012

    Global Markets Direct
    40 pages
    Introduction Global Markets Direct’s, 'Blepharitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Blepharitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
    Englisch | Report | SKU: 317989
  9. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Osteoarthritis Pain – Pipeline Review, H1 2013

    Global Markets Direct
    127 pages
    Introduction Global Markets Direct’s, 'Osteoarthritis Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis Pain, complete with latest updates, and special features on late-stage and discontinued projects. It a
    Englisch | Report | SKU: 318629
  10. $2,000.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2014

    Global Markets Direct
    50 pages
    Global Markets Direct’s, ‘Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2014’, provides an overview of the Thrombotic Thrombocytopenic Purpura’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura, complete with comparative analysis
    Englisch | Zukunftsanalyse | SKU: 394151
  11. $1,500.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Bausch & Lomb Incorporated – Product Pipeline Review – 2012

    Global Markets Direct
    126 pages
    Introduction Global Market Direct’s pharmaceuticals report, “Bausch & Lomb Incorporated - Product Pipeline Review - 2012” provides data on the Bausch & Lomb Incorporated’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued an
    Englisch | Product Pipeline Review | SKU: 317701

Items 1 to 10 of 2139 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 214